Physician profile
Daniel Ilya Wolfson
NPI 1093339830
$4,842.10
in general payments reported to CMS, 2019-2025
11 companies · $873 in 2025
The $873 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $56.19 · 2021: $697 · 2022: $902 · 2023: $1,456 · 2024: $857 · 2025: $873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,394 · Education: $755 · Travel and Lodging: $36.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,394.22 |
| Education | $754.97 |
| Travel and Lodging | $36.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,683.34 | 2022-2025 | Infinity Occipitocervical Upper Thoracic System, Cd Horizon Spinal System, Midas Rex |
| Medical Device Business Services, INC. | $1,410.92 | 2021-2025 | Actis |
| Depuy Synthes Sales INC. | $543.67 | 2022-2025 | Fibergraft Bg Morsels, X-Pac, Viper |
| Si-Bone, INC. | $285.92 | 2021 | |
| Boston Scientific Corporation | $166.60 | 2022 | |
| Icotec Medical INC. | $154.99 | 2023 | Icotec Blackarmor Spine System |
| Gt Medical Technologies, INC | $151.58 | 2023 | Gammatile |
| Stryker Corporation | $150.97 | 2023-2024 | N/A, Core |
| Augmedics INC. | $137.22 | 2021-2023 | Xvision |
| Integra Lifesciences Corporation | $121.45 | 2020-2023 | Codman Hakim, Cusa Clarity, Codman Certas |
| Ethicon US, LLC | $35.44 | 2025 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wolfson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.